Results 31 to 40 of about 6,030,066 (175)

Cutaneous leishmaniasis.

, 2007
Cutaneous leishmaniasis is endemic in the tropics and neotropics. It is often referred to as a group of diseases because of the varied spectrum of clinical manifestations, which range from small cutaneous nodules to gross mucosal tissue destruction ...
Claude Pirmez, Brooker, Simon, Louzir, Hechmi, Louzir, H., Reithinger, R., Jean-Claude Dujardin, Simon Brooker, Reithinger, Richard, Dujardin, Jean-Claude, Dujardin, J. C., Hechmi Louzir, Pirmez, Claude, Alexander, B., Alexander, Bruce, Richard Reithinger, Bruce Alexander, Pirmez, C., Brooker, S.   +17 more
core   +1 more source

Differential Susceptibility to Antimony in Strains and Clinical Isolates of Leishmania amazonensis from Brazil: In Vitro and In Vivo Studies and Implications for Drug Response and Treatment Failure

Pathogens
In Brazil, cutaneous leishmaniasis is endemic and may be caused by Leishmania amazonensis. This species is the second most prevalent species in that country, and it is responsible for localized cutaneous and diffuse cutaneous leishmaniasis.
Victor de Sousa Agostino, Leonardo F. Geres, Stéphane de la Roca, Beatriz T. de Moraes, Juliana I. Aoki, Elizabeth M. Coser, Nilson Branco, Adriano C. Coelho   +7 more
doaj   +1 more source

The transmission dynamics of canine American cutaneous leishmaniasis in Huánuco, Peru. [PDF]

, 2003
The epidemiology of canine American cutaneous leishmaniasis (ACL) due to Leishmania (Viannia) spp. was investigated in Huánuco, Peru to 1) describe the natural course of canine L.
Reithinger, Richard, Espinoza, Juan Canales, Davies, Clive R   +2 more
core   +1 more source

The Effectiveness of Perovskia abrotanoides Extract Topical Formulation on the Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial

Journal of Research in Pharmacy Practice
Objective: Despite many attempts to treat leishmaniasis, new approaches are necessary to reduce the burden of disease. Perovskia abrotanoides (Brazambel) has shown significant effects against Leishmania parasites in some studies.
Maryam Sadat Tayebi, Nazila Poostiyan, Masoud Sadeghi Dinani, Erfaneh Ghassami, Rasool Soltani   +4 more
doaj   +1 more source

Multiple hybrid genotypes of Leishmania (viannia) in a focus of mucocutaneous Leishmaniasis. [PDF]

, 2007
The principal agent of mucocutaneous leishmaniasis (MCL) is the South American protozoan parasite Leishmania (Viannia) braziliensis. This organism is generally considered to be clonal, that is, it does not to undergo genetic exchange.
Miles, Michael A, Roncal, Norma, Nolder, Debbie, Llanos-Cuentas, Alejandro, Davies, Clive R   +4 more
core   +1 more source

Artificial Intelligence in Dermatology: Current Applications and Future Directions

JEADV Clinical Practice, EarlyView.
This scoping review of 56 studies maps AI applications in dermatology. Image‐based classification for skin cancer detection dominates (48%), followed by clinical decision support (21%), teledermatology triage (11%), and predictive analytics (11%). While deep learning algorithms demonstrate diagnostic performance comparable to clinicians in controlled ...
Sofía Pérez‐Lalinde, Francisco Flores   +1 more
wiley   +1 more source

MILTEFOSINE IN TREATMENT OF OLD WORLD CUTANEOUS LEISHMANIASIS IN PAKISTAN

Pakistan Armed Forces Medical Journal, 2010
Objective: To evaluate the efficacy of miltefosine in the treatment of cutaneous leishmaniasis Study Design: Uncontrolled, open label, quasi-experimental study Place and Duration of Study: The study was carried out in Military Hospital Rawalpindi and ...
Brig Nasser Rashid Dar, Simeen Ber Rehman, Muhammad Abbas, Muhammad Amjad, Asher Ahmed Mashhood, Qamar ., Khalid Ranjha, Sibghat Ullah Rao   +7 more
doaj   +2 more sources

Development and Characterization of Liposomes Containing a Zn(II) Porphyrin Derivative for the Application of Photodynamic Therapy in the Treatment of Breast Cancer

Lasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives This study aims to synthesize and characterize lipid nanosystems (liposomes) for the incorporation of a Zn(II) porphyrin derivative, Zn(II) meso‐tetrakis(N‐n‐hexylpyridinium‐2‐yl)porphyrin (ZnTnHex‐2‐PyP4+, ZnPH), intending to employ an alternative method of treatment, such as photodynamic therapy (PDT), for breast cancer (BC ...
Kammila Martins Nicolau Costa, José Ferreira Sarmento‐Neto, Júlio Santos Rebouças, Ricardo Olímpio de Moura, John F. Callan, João Augusto Oshiro‐Junior   +5 more
wiley   +1 more source

Structures, targets and recent approaches in anti-leishmanial drug discovery and development. [PDF]

, 2011
Recent years have seen a significant improvement in available treatment options for leishmaniasis. Two new drugs, miltefosine and paromomycin, have been registered for the treatment of visceral leishmaniasis (VL) in India since 2002.
Karin Seifert, Seifert, Karin
core   +1 more source

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source